Urinary Incontinence - 2018 Pipeline Insight Report - ResearchAndMarkets.com

September 28, 2018

DUBLIN--(BUSINESS WIRE)--Sep 28, 2018--The “Urinary Incontinence - Pipeline Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Urinary Incontinence development.The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.


The report provides a snapshot of the pipeline development for Urinary IncontinenceThe report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for Urinary IncontinenceThe report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical informationProvides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Urinary IncontinenceThe report also covers the dormant and discontinued pipeline projects related to Urinary IncontinenceCompanies FeaturedAstellas Pharma Inc.CelogosCook MyoSite IncorporatedFemmePharma Global Healthcare Inc.GTx Inc.Innovacell Biotechnologie AGIpsen S.A.Outpost Medicine LimitedTaiho Pharmaceutical Co. Ltd.Takeda Pharmaceutical Company LimitedTheraVida Inc.

Key Topics Covered

1. Report Introduction

2. Urinary Incontinence Overview

3. Pipeline Therapeutics

An Overview of Pipeline Products for Urinary Incontinence

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

7. Therapeutic Assessment

Assessment by Route of AdministrationAssessment by Stage and Route of AdministrationAssessment by Molecule TypeAssessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

Product DescriptionResearch and DevelopmentProduct Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/3t8jxw/urinary?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180928005287/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Urological Disorders Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/28/2018 09:02 AM/DISC: 09/28/2018 09:02 AM


Update hourly